Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar;71(3):586-594.
doi: 10.1007/s12020-021-02649-6. Epub 2021 Mar 4.

Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis

Affiliations
Review

Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis

Hanna Nowotny et al. Endocrine. 2021 Mar.

Abstract

Adrenal insufficiency (AI) is a life-threatening condition requiring life-long glucocorticoid (GC) substitution therapy, as well as stress adaptation to prevent adrenal crises. The number of individuals with primary and secondary adrenal insufficiency in Europe is estimated to be 20-50/100.000. A growing number of AI cases are due to side effects of GC treatment used in different treatment strategies for cancer and to immunotherapy in cancer treatment. The benefit of hormone replacement therapy is evident but long-term adverse effects may arise due to the non-physiological GC doses and treatment regimens used. Given multiple GC replacement formulations available comprising short-acting, intermediate, long-acting and novel modified-release hydrocortisone as well as subcutaneous formulations, this review offers a concise summary on the latest therapeutic improvements for treatment of AI and prevention of adrenal crises. As availability of various glucocorticoid formulations and access to expert centers across Europe varies widely, European Reference Networks on rare endocrine conditions aim at harmonizing treatment and ensure access to specialized patient care for individual case-by-case treatment decisions. To improve the availability across Europe to cost effective oral and parenteral formulations of hydrocortisone will save lives.

Keywords: Adrenal crisis; Adrenal insufficiency; Congenital adrenal hyperplasia; Glucocorticoid replacement; Hydrocortisone; Stress instructions.

PubMed Disclaimer

Conflict of interest statement

N.R. is PI of the Chronocort® Phase III and extension study and of the EU-AIR SHP617-400-P40012 study. The other authors report no conflicts of interest in this work.

Figures

Fig. 1
Fig. 1
European steroid emergency card for children (left) and adults (right) in the English version (https://adrenals.eu/emergency-card/)
Fig. 2
Fig. 2
Overview on symptoms, causes and preventive therapies of adrenal crisis. ICU intensive care unit, PAI primary adrenal insufficiency, SAI secondary adrenal insufficiency, GC glucocorticoid, i.m. intramuscular, i.v. intravenously, s.c. subcutaneously, PONV postoperative nausea and vomiting, HC hydrocortisone, mg milligram, h hour [, –, –68]
Fig. 3
Fig. 3
Summary of treatment of adrenal crisis in adults and children in the hospital setting. i.v. intravenously, i.m. intramuscular, h hour, CVP central venous pressure, IBP invasive blood pressure, ICU intensive care treatment [, –72]

Similar articles

Cited by

References

    1. Charmandari E, Nicolaides NC, Chrousos GP. Adrenal insufficiency. Lancet. 2014;383(9935):2152–2167. doi: 10.1016/S0140-6736(13)61684-0. - DOI - PubMed
    1. Arlt W, Allolio B. Adrenal insufficiency. Lancet. 2003;361(9372):1881–1893. doi: 10.1016/S0140-6736(03)13492-7. - DOI - PubMed
    1. T. Li, J.L. Cunningham, W.P. Gilliam, L. Loukianova, D.M. Donegan, I. Bancos, Prevalence of opioid-induced adrenal insufficiency in patients taking chronic opioids. J. Clin. Endocrinol. Metab. 105(10) (2020). 10.1210/clinem/dgaa499 - PMC - PubMed
    1. F. de Vries, M. Bruin, D.J. Lobatto, O.M. Dekkers, J.W. Schoones, W.R. van Furth, A.M. Pereira, N. Karavitaki, N.R. Biermasz, A.H. Zamanipoor Najafabadi, Opioids and their endocrine effects: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 105(3) (2020). 10.1210/clinem/dgz022 - PMC - PubMed
    1. Oster H, Challet E, Ott V, Arvat E, de Kloet ER, Dijk DJ, Lightman S, Vgontzas A, Van Cauter E. The functional and clinical significance of the 24-hour rhythm of circulating glucocorticoids. Endocr. Rev. 2017;38(1):3–45. doi: 10.1210/er.2015-1080. - DOI - PMC - PubMed

Publication types

LinkOut - more resources